ArticleNature materials2024
Compensating losses in polariton propagation with synthesized complex frequency excitation.
Article in Nature materials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Low-temperature hyperbolic phonon polaritonics with suppressed phononic scattering.Science advances · 2026Article
- Loss Compensation and Coherent Virtual Absorption via Virtual Complex Frequency Wave Excitation.Nanophotonics (Berlin, Germany) · 2026Article
- Lasing-like dynamics with virtual gain driven by complex-frequency excitations.Nature communications · 2026Article
- Ultrabroadband Spacetime Nanoscopy of Terahertz Polaritons in a van der Waals Cavity.Small (Weinheim an der Bergstrasse, Germany) · 2026Article
- Synthetic gain for electron-beam spectroscopy.Nature communications · 2026Article
- Ideal optical antimatter using passive lossy materials under complex frequency excitation.Light, science & applications · 2026Article
- Fundamental optical phenomena of strongly anisotropic polaritons at the nanoscale.Nature nanotechnology · 2026Review
- Polaritonic quantum matter.Nanophotonics (Berlin, Germany) · 2025Review
- Physics-informed deep learning for plasmonic sensing of nanoscale protein dynamics in solution.Science advances · 2025Article
- Deep Learning Design for Loss Optimization in Metamaterials.Nanomaterials (Basel, Switzerland) · 2025Article
- Observation of non-Hermitian boundary induced hybrid skin-topological effect excited by synthetic complex frequencies.Nature communications · 2024Article
- "The unreasonable effectiveness of mathematics" in evading polaritonic losses.Nature materials · 2024Article
- Complex-frequency waves: beat loss and win sensitivity.Light, science & applications · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Surface plasmon polaritons and phonon polaritons offer a means of surpassing the diffraction limit of conventional optics and facilitate efficient energy storage, local field enhancement and highsensitivity sensing, benefiting from their subwavelength confinement of light. Unfortunately, losses severely limit the propagation decay length, thus restricting the practical use of polaritons. While optimizing the fabrication technique can help circumvent the scattering loss of imperfect structures, the intrinsic absorption channel leading to heat production cannot be eliminated. Here, we utilize synthetic optical excitation of complex frequency with virtual gain, synthesized by combining the measurements made at multiple real frequencies, to compensate losses in the propagations of phonon polaritons with dramatically enhanced propagation distance. The concept of synthetic complex frequency excitation represents a viable solution to the loss problem for various applications including photonic circuits, waveguiding and plasmonic/phononic structured illumination microscopy.
Identifiers
38191633What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.